Assertion Supported AI assessment confidence: 95% certainty 4/5 debate potential 2/5

Mask: Tech IPO revenue benchmarks shifted from $27M to $150M

Clate Mask · 637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask · Apr 22, 2017 · at 13:42

Infusionsoft CEO Clate Mask explains why the revenue threshold required for tech companies to go public has increased dramatically.

0:00 / 0:05exact quote · 6.0s

720p mp4 · rendered on demand · StarZero watermark

“One 50 is more like what it is today. The contact went public at twenty seven million.”

quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →

The claim, plainly

Constant Contact went public at approximately $27 million in revenue.

a quote alone can be ambiguous, so this restates it with the references and context of the conversation around it resolved. AI-written; the tape below the player is the source.

Assessment

According to Constant Contact, Inc.'s Form S-1 registration statement and prospectus filed with the U.S. Securities and Exchange Commission for its October 2007 initial public offering (IPO), the company reported revenue of $27.6 million for the full fiscal year 2006 (the preceding full fiscal year prior to the IPO). This directly aligns with the speaker's statement that Constant Contact went public at approximately $27 million in revenue.

Constant Contact filed its Form S-1 registration statement with the SEC in 2007 ahead of its October 3, 2007 IPO.
SEC Form S-1 reported fiscal year 2006 revenue of $27.6 million, an 88% increase from $14.7 million in 2005.

Checked against

[1] 247wallst.com [2] cheddarflow.com [3] sec.gov [4] sec.gov [5] sec.gov [6] sec.gov [7] wikipedia.org [8] wikipedia.org

site:sec.gov/Archives/edgar/data/1405277 "Revenue" "2006" "2005" "Constant Contact" IPO date "2007" pricing "October" OR "November" OR "December" Constant Contact S 1 IPO revenue 2006 2007 SEC filing

assessed as of 2026-09-02

This assessment is an AI reading of a public statement, made against the cited references with the confidence shown. It can be wrong. The quote, the tape and the references are all on this page; if something is off, use report an error below. full disclaimer →

Mentioned

Clate Mask Constant Contact

⚑ Spot an error? Report it

More from Clate Mask

Assertion Not checkable as stated

Mask: Upfront setup fees drove Infusionsoft's monthly churn from 8% to 2%

“Would you directly associate that upfront fee with being the number one mover of your churn going from eight to two percent? Absolutely.”

Clate Mask Apr 22, 2017 ▶ 18:50 637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

Disclosure

Clate Mask: Infusionsoft is profitable and no longer requires VC funding

“We've grown to a point where we're not dependent on venture capital. We're not dependent on outside revenues or outside funding sources. And we've built a profitable growing business that no longer requires that kind of funding.”

Clate Mask May 27, 2018 ▶ 2:00 1037 Clate Mask on ICON, Infusionsoft IPO, Exit Strategy

Insight

Mask: Companies should always stay private if private capital exists

“We just felt like there's no, it's always better to stay private longer. So if you can and you can get the capital, then do it.”

Clate Mask Apr 22, 2017 ▶ 15:18 637: Reason Infusionsoft Didn't IPO, Passes $100M ARR, $125M Raised, Helping 45,000 SMB's With Marketing and Sales Automation with CEO Clate Mask

Assertion Not checkable as stated

Mask: Infusionsoft improved its LTV:CAC ratio while expanding downmarket

“The LTV CAC is stronger than it was before, which is really great because a lot of times when you serve a less sophisticated customer, your CAC is going to go up or your LTV will go down. That hasn't been the case. We've got a better ratio than we had before.”

Clate Mask Dec 19, 2018 ▶ 11:31 1243 Infusionsoft North of $100m in ARR, Details of Mars Mission to 5m SMB Customers

Disclosure

Mask: Infusionsoft lowered LTV by introducing a $99 price point

“Our LTV has gone down as well because we're bringing on a custom, because we now have a 99 dollar price point and customers who can come in without paying, you know, 250 or 300 dollars out the gate.”

Clate Mask Dec 19, 2018 ▶ 11:52 1243 Infusionsoft North of $100m in ARR, Details of Mars Mission to 5m SMB Customers

Assertion Not checkable as stated

Mask confirms Infusionsoft has surpassed a $100 million revenue run rate

“But yeah, we're over the hundred million revenue rate at this point.”

Clate Mask Dec 19, 2018 ▶ 15:45 1243 Infusionsoft North of $100m in ARR, Details of Mars Mission to 5m SMB Customers

Mask: Tech IPO revenue benchmarks shifted from $27M to $150M

More from Clate Mask

Turn any episode into a week of clips.